Prajakta Gadgil

Prajakta Gadgil

Takeda Pharmaceutical Company Limited - - / Japan
Others
AD Scientific Index ID: 4624924
武田薬品工業株式会社
person_outline Prajakta Gadgil's MOST POPULAR ARTICLES
1-) The evolving druggability and developability space: Chemically modified new modalities and emerging small moleculesW Yang, P Gadgil, VR Krishnamurthy, M Landis, P Mallick, D Patel, ...The AAPS Journal 22 (2), 1-14, 2020302020
2-) Enhanced brain delivery with lower hepatic exposure of lazaroid loaded nanostructured lipid carriers developed using a design of experiment approachP Gadgil, J Shah, DSL ChowInternational Journal of Pharmaceutics 544 (1), 265-277, 2018122018
3-) Assessing the Utility ofIn VitroScreening Tools for PredictingBio-Performance of Oral Peptide DeliverP Gadgil, C Alleyne, KI Feng, M Hu, M Gindy, AV Buevich, S Fauty, ...Pharmaceutical Research 36 (151), 2019122019
4-) Phosphaplatin anti-tumor effect enhanced by liposomes partly via an up-regulation of PEDF in breast cancerL Belkacemi, JL Atkins, LU Yang, P Gadgil, AK Sater, DS Chow, RN Bose, ...Anticancer Research 38 (2), 623-646, 2018132018
5-) UPLC–MS/MS assay of 21-aminosteroid (lazaroid U74389G) for application in pharmacokinetic studyP Gadgil, F Ibrahim, DSL ChowJournal of Pharmaceutical and Biomedical Analysis 122, 90-97, 201652016